Cala HO

Language: Spanish
References: 16
Page: 33-43
PDF size: 134.77 Kb.

ABSTRACT

Introduction: Down syndrome is a genetic disease that constitutes the first cause of mental retardation. The increase of the quality of life in the population, the development of equipments to the carry out the genetic counselling, the improvement of health services and education which includes the rehabilitation, all these motivate the continuing effort to control the disease.
Objective: to characterize Down syndrome from the clinical and epidemiological point of view in pediatric population, Pinar del Rio.
Material and Method: a descriptive, longitudinal study was carried out in patients with the diagnosis of Down syndrome and attending at Provincial Center of Medical Genetics, Pinar del Rio. The sample included 110 patients younger than 17 years old, 11 month and 29 days. Clinical histories were reviewed and an informed consent was applied.
Results: female sex prevailed; maternal ages from 31 to 35 were in risk for Down syndrome presentation. Ventricular and Atrial septal defects were the most frequent cardiovascular congenital defects. The greatest percentage of cases with abnormal karyotype belonged to a free trisomy.
Conclusions: by means of a clinical and epidemiological study a better management of disabling sequels of the disease is achieved, along with scientific necessary data to carry out the genetic counselling. The study comprised 110 patients younger than 18 years old who attended at Provincial Center of Medical Genetics in Pinar del Rio (Cuba) all along 1993-2011.

REFERENCES

1. Lorenzi H, Duvall N, Cherry SM, Reeves RH, Roper RJ. PCR prescreen for genotyping the Ts65Dn mouse model of Down syndrome. Biotechniques. Ene 2010; 48(1).

2. Boff J, Aquino Caregnato RC. História oral de mulheres com filhos portadores de Síndrome de Down. Texto & contexto enferm. Jul-Sep 2008; 17(3).

3. Cammarata-Scalisi F, Da Silva G, Cammarata-Scalisi G, Sifuentes A. Historia del Síndrome de Down. Un recuento lleno de protagonistas. Can Pediatr. 2010; 34(3).

4. Guedj F, Sébrié C, Rivals I, Ledru A, Paly E, Bizot JC, et al. Green Tea Polyphenols Rescue of Brain Defects Induced by Overexpression of DYRK1A. Plos ONE. Feb 2009; 4(2).

5. Colectivo de autores. Por la vida. Estudio psicosocial de las personas con discapacidades y estudio psicopedagógico social y clínico-genético de las personas con retraso mental en Cuba. Ciudad de La Habana: Casa Editorial Abril, 2003.

6. Alves-Sampaio A, Troca-Marín JA, Montesinos ML. NMDA-mediated regulation of DSCAM dendritic local translation is lost in a mouse model of Down's syndrome. J Neurosci. Oct 2010; 30(40).

7. Lyle R, Béna F, Gagos S, Gehrig C, Lopez G, Schinzel A, et al. Lyle et al. Genotype-phenotype correlations in Down syndrome identified by array CGH in 30 cases of partial trisomy and partial monosomy chromosome 21. Eur J Hum Genet. 2009; 17.

8. Netzer WJ, Powell C, Nong Y, Blundell J, Wong L, Duff K, et al. Lowering betaamyloid levels rescues learning and memory in a Down syndrome model. PLoS One. Jun 2010; 5(6).

9. Sussan TE, Yang A, Li F, Ostrowski MC, Reeves RH. Trisomy represses apc(min)- mediated tumours in mouse models of Down's syndrome. Nature. Ene 2008; 451(3).

10. Korbel JO, Tirosh-Wagner T, Eckehart Urban A, Chen XN, Kasowski M, Dai L, et al. The genetic architecture of Down syndrome phenotypes revealed by highresolution analysis of human segmental trisomies. Proc Natl Acad Sci. Jul 2009; 106(29).

11. Stankiewicz MJ, Crispino JD. ETS2 and ERG promote megakaryopoiesis and synergize with alterations in GATA-1 to immortalize hematopoietic progenitor cells. Blood. Abr 2009; 113(14).

12. Jijón M. Genética y Síndrome de Down. Características generales. En: Jijón M. Síndrome de Down. Pautas mínimas para su entendimiento y atención. 2a ed. Quito: G&R Imprenta; 2010. p. 33-46

13. Voronov SV, Frere SG, Giovedi S, Pollina EA, Borel C, Zhang H, et al. Synapjanine 1-linked phosphoinositide dishomeostasis and cognitive deficits in mouse models of Down's syndrome. Proc Natl Acad Sci. Jun 2008; 105(27).

14. Jijón M. El niño y niñas Down ante las enfermedades. Características generales. En: Jijón M. Síndrome de Down. Pautas mínimas para su entendimiento y atención. 2a ed. Quito: G&R Imprenta; 2010. p. 132-5

15. Kimura R, Kamino K, Yamamoto M, Nuripa A, Kida T, Kazui H, et al. The DYRK1A gene, encoded in chromosome 21 Down syndrome critical region, bridges between â-amyloid production and tau phosphorylation in Alzheimer disease. Hum. Mol. Genet. 2007; 16(1).

16. Trazzi S, Mitrugno VM, Valli E, Fuchs C, Rizzi S, Guidi S, et al. APP-dependent up regulation of Ptch1 underlies proliferation impairment of neural precursors in Down syndrome. Hum Mol Genet. Ene 2011; 20(8).